Literature DB >> 20037206

Genetic association of DLG5 R30Q with familial and sporadic inflammatory bowel disease in men.

Z Lin1, L Poritz, A Franke, T Y Li, A Ruether, K A Byrnes, Y Wang, A W Gebhard, C MacNeill, N J Thomas, R Wu, S Schreiber, W A Koltun.   

Abstract

BACKGROUND: The association of DLG5 R30Q with IBD has been replicated in several populations, but is not statistically significant in others. We studied the incidence of DLG5 alleles in a population of IBD patients from Pennsylvania.
METHODS: DLG5 R30Q (rs1248696) and G1066G (rs1248634) were analyzed with PCR-based RFLP methods in a total of 521 subjects, that included 105 individuals with IBD and 139 without IBD from a familial IBD registry, 107 with sporadic IBD, and 170 unrelated healthy controls. R30Q was further analyzed with SNPlex Genotyping System in 473 samples.
RESULTS: RFLP genotyping data showed that, DLG5 R30Q was significantly associated with IBD overall (p=0.006), and separately with CD (p=0.009) and UC (p=0.024). The association of R30Q with IBD was entirely due to a male-associated effect (male vs female p=0.015 vs 0.241 (IBD), p=0.024 vs 0.190 (CD), and p=0.019 vs 0.575 (UC)). The frequency of the A allele carriage was elevated in both affected and unaffected members in the familial IBD cohort compared to healthy controls (p=0.037). In the family pedigrees, we observed differences in the expression of IBD in individuals carrying the A allele between families.
CONCLUSIONS: In the studied population, DLG5 R30Q was associated with all forms of IBD. An elevated presence of the R30Q variant was observed in all members of a familial IBD registry. This association of the R30Q variant with IBD was male-specific.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20037206      PMCID: PMC3835024          DOI: 10.3233/DMA-2009-0662

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  5 in total

1.  Genetic variants and monoallelic expression of surfactant protein-D in inflammatory bowel disease.

Authors:  Zhenwu Lin; Gerrit John; John P Hegarty; Arthur Berg; Wei Yu; Yunhua Wang; Ashley A Kelly; Blaise Z Peterson; Lisa S Poritz; Joanna Floros; Walter A Koltun
Journal:  Ann Hum Genet       Date:  2011-07-25       Impact factor: 1.670

2.  A general model for multilocus epistatic interactions in case-control studies.

Authors:  Zhong Wang; Tian Liu; Zhenwu Lin; John Hegarty; Walter A Koltun; Rongling Wu
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

3.  Role of Dlg5/lp-dlg, a membrane-associated guanylate kinase family protein, in epithelial-mesenchymal transition in LLc-PK1 renal epithelial cells.

Authors:  Takuhito Sezaki; Kohki Inada; Takayuki Sogabe; Kumiyo Kakuda; Lucia Tomiyama; Yohsuke Matsuno; Takafumi Ichikawa; Michinori Matsuo; Kazumitsu Ueda; Noriyuki Kioka
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

Review 4.  Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease.

Authors:  Tomasz J Ślebioda; Zbigniew Kmieć
Journal:  Mediators Inflamm       Date:  2014-06-17       Impact factor: 4.711

5.  Meta-analysis of associations between DLG5 R30Q and P1371Q polymorphisms and susceptibility to inflammatory bowel disease.

Authors:  Yunhai Li; Ping Chen; Jiazheng Sun; Jing Huang; Hongtao Tie; Liangliang Li; Hongzhong Li; Guosheng Ren
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.